ESR1 and cancer: With regard to the stromal CD8+ T cell counts across these subtypes, ER+ cancers demonstrated no difference based on VCAN status, whereas ER− cancers actually contained fewer stromal CD8+ T cells/HPF in VCAN-undetectable disease (p = 0.03; Supplementary Figure S2).